You are here

Article metrics

Article menu

Download PDFPDF

Review
Key design considerations on comparative clinical efficacy studies for biosimilars: adalimumab as an example

 

Online download statistics by month:

Online download statistics by month: February 2016 to September 2024

AbstractFullPdf
Feb 201616570115
Mar 2016975055
Apr 20161306652
May 20161687452
Jun 201616473124
Jul 2016726144
Aug 2016794442
Sep 2016824752
Oct 20161057056
Nov 2016887732
Dec 2016423225
Jan 201783923
Feb 201701318
Mar 201711812
Apr 201715612
May 201704111
Jun 2017214521
Jul 2017303013
Aug 201735357
Sep 2017494915
Oct 201744448
Nov 2017525023
Dec 2017272717
Jan 2018454512
Feb 201831239
Mar 201842468
Apr 201810411019
May 201812412526
Jun 201813613619
Jul 2018999912
Aug 201816116125
Sep 201814114113
Oct 201821421420
Nov 201827927727
Dec 201835735532
Jan 201929329347
Feb 201930430335
Mar 201914014020
Apr 2019999932
May 2019797918
Jun 2019616217
Jul 2019525015
Aug 2019949325
Sep 2019717116
Oct 2019747418
Nov 2019767520
Dec 2019454515
Jan 2020464415
Feb 2020616129
Mar 2020464527
Apr 2020676724
May 202010210330
Jun 2020534918
Jul 202042437
Aug 2020423639
Sep 2020837734
Oct 2020484721
Nov 2020716414
Dec 2020776714
Jan 2021565316
Feb 2021433812
Mar 2021726419
Apr 2021554717
May 2021838034
Jun 2021404020
Jul 2021333314
Aug 2021494920
Sep 2021292910
Oct 2021555131
Nov 2021322222
Dec 202123235
Jan 202227196
Feb 202216176
Mar 2022514419
Apr 2022706014
May 202212211625
Jun 2022646015
Jul 2022424215
Aug 2022747418
Sep 2022555323
Oct 2022857617
Nov 202249419
Dec 2022413510
Jan 2023514918
Feb 2023736914
Mar 2023826335
Apr 20231049526
May 2023595521
Jun 202311811926
Jul 2023999530
Aug 2023848230
Sep 2023727033
Oct 20239910022
Nov 202311210721
Dec 202319418121
Jan 20242424251
Feb 202423122915
Mar 202413813819
Apr 202418917952
May 2024808023
Jun 2024919012
Jul 202410910829
Aug 202447439
Sep 202449468
Total869081182713